Immediate Impact

63 standout
Sub-graph 1 of 20

Citing Papers

Injectable Microgels with Hybrid Exosomes of Chondrocyte‐Targeted FGF18 Gene‐Editing and Self‐Renewable Lubrication for Osteoarthritis Therapy
2024 Standout
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
2 intermediate papers

Works of G Levy being referenced

A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
2019
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
2018

Author Peers

Author Last Decade Papers Cites
G Levy 247 25 41 116 68 8 317
Jérémy Maillet 229 7 54 89 99 10 336
Matthew J. Wood 180 9 43 59 84 11 362
Irina Kerna 180 23 41 68 88 12 282
Elena Tripel 256 4 83 92 63 14 342
Frank Pessler 224 4 35 48 61 13 320
Yoshinari Fujita 131 8 67 63 89 10 288
Brendon Richbourgh 131 5 39 55 135 7 353
A. Florescu 173 10 37 21 44 9 303
C.M.G. Thomas 157 5 40 48 104 8 311
Karsyn N. Bailey 178 12 35 40 86 7 287

All Works

Loading papers...

Rankless by CCL
2026